Stockreport

Neoleukin Therapeutics Announces Appointment of Robert K. Ho as Chief Financial Officer

Neoleukin Therapeutics, Inc.  (NLTX) 
PDF SEATTLE, Feb. 25, 2020 (GLOBE NEWSWIRE) -- Neoleukin Therapeutics, Inc. (“Neoleukin”) (Nasdaq: NLTX), a biopharmaceutical company utilizing sophisticated computational [Read more]